Effect of the novel anxiolytic drug deramciclane on cytochrome P 450 2D6 activity as measured by desipramine pharmacokinetics

Author: Laine Kari   Bruyn Steven   Björklund Harry   Rouru Juha   Hänninen Jutta   Scheinin Harry   Anttila Markku  

Publisher: Springer Publishing Company

ISSN: 0031-6970

Source: European Journal of Clinical Pharmacology, Vol.59, Iss.12, 2004-02, pp. : 893-898

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content